These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8265825)

  • 1. Neurologic complications of antiphospholipid antibodies.
    Brey RL; Gharavi AE; Lockshin MD
    Rheum Dis Clin North Am; 1993 Nov; 19(4):833-50. PubMed ID: 8265825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibodies and ischemic stroke.
    Brey RL
    Heart Dis Stroke; 1992; 1(6):379-82. PubMed ID: 1344135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological involvement in antiphospholipid antibodies syndrome (APS).
    Amoroso A; Mitterhofer AP; Ferri GM; Galluzzo S; Vadacca M; Afeltra A
    Eur Rev Med Pharmacol Sci; 1999; 3(5):205-9. PubMed ID: 11075618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies and migraine: a retrospective study of 428 patients with inflammatory connective tissue diseases.
    Tănăsescu R; Nicolau A; Caraiola S; Ticmeanu M; Cojocaru IM; Frăsineanu A; Ionescu R; Hristea A; Ene A; Anghel D; Tănăsescu R; Băicuş C
    Rom J Intern Med; 2007; 45(4):355-63. PubMed ID: 18767411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral manifestations in the antiphospholipid (Hughes) syndrome.
    Sanna G; D'Cruz D; Cuadrado MJ
    Rheum Dis Clin North Am; 2006 Aug; 32(3):465-90. PubMed ID: 16880079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurologic manifestations associated with antiphospholipid antibodies. Or what remains of neurolupus?].
    Hachulla E; Leys D; Deleume JF; Pruvo JP; Devulder B
    Rev Med Interne; 1995; 16(2):121-30. PubMed ID: 7709101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
    Komatireddy GR; Wang GS; Sharp GC; Hoffman RW
    J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lupus anticoagulants versus antiphospholipid antibodies].
    Pereira MI
    Acta Med Port; 1998 Apr; 11(4):349-57. PubMed ID: 9644846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association between antiphospholipid antibodies and thrombocytopenia in patients with Wegener's granulomatosis.
    Meyer MF; Schnabel A; Schatz H; Gross WL
    Semin Arthritis Rheum; 2001 Aug; 31(1):4-11. PubMed ID: 11503134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid syndrome: an evolving story.
    Robertson B; Greaves M
    Blood Rev; 2006 Jul; 20(4):201-12. PubMed ID: 16442679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiphospholipid thrombosis syndrome and acquired activated protein C resistance].
    Wu J; Zhou Z; Li X; Li X; Chen Y; Wang G; Xu X; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2000 Mar; 21(3):122-4. PubMed ID: 11876968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ischemic stroke with antiphospholipid antibody].
    Kitagawa Y; Ohkuma H; Tokuoka K
    Brain Nerve; 2008 Oct; 60(10):1144-58. PubMed ID: 18975602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid syndrome.
    Gezer S
    Dis Mon; 2003 Dec; 49(12):696-741. PubMed ID: 14679358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurological aspects in antiphospholipid syndrome].
    Kitagawa Y
    Rinsho Shinkeigaku; 2003 Nov; 43(11):744-7. PubMed ID: 15152454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W; Matthias T; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
    Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
    Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological manifestations of antiphospholipid syndrome.
    Rodrigues CE; Carvalho JF; Shoenfeld Y
    Eur J Clin Invest; 2010 Apr; 40(4):350-9. PubMed ID: 20192975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.